PortfoliosLab logoPortfoliosLab logo
JSPR vs. GD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JSPR vs. GD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jasper Therapeutics, Inc. (JSPR) and General Dynamics Corporation (GD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JSPR achieves a -72.60% return, which is significantly lower than GD's 2.88% return.


JSPR

1D
10.71%
1M
-44.46%
YTD
-72.60%
6M
-73.74%
1Y
-90.26%
3Y*
-65.95%
5Y*
10Y*

GD

1D
-1.90%
1M
0.14%
YTD
2.88%
6M
0.34%
1Y
25.43%
3Y*
19.79%
5Y*
15.39%
10Y*
12.11%
*Multi-year figures are annualized to reflect compound growth (CAGR)

JSPR vs. GD - Yearly Performance Comparison


2026 (YTD)20252024202320222021
JSPR
Jasper Therapeutics, Inc.
-72.60%-91.44%170.98%63.39%-93.85%-37.90%
GD
General Dynamics Corporation
2.88%30.39%3.52%7.13%21.69%6.59%

Correlation

The correlation between JSPR and GD is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Sep 24, 2021

0.09

Fundamentals

Market Cap

JSPR:

$14.38M

GD:

$94.11B

EPS

JSPR:

-$2.87

GD:

$15.92

PB Ratio

JSPR:

4.23

GD:

3.61

Total Revenue (TTM)

JSPR:

$0.00

GD:

$53.81B

Gross Profit (TTM)

JSPR:

-$290.00K

GD:

$7.48B

EBITDA (TTM)

JSPR:

-$72.26M

GD:

$6.26B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JSPR vs. GD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JSPR
JSPR Risk / Return Rank: 66
Overall Rank
JSPR Sharpe Ratio Rank: 88
Sharpe Ratio Rank
JSPR Sortino Ratio Rank: 33
Sortino Ratio Rank
JSPR Omega Ratio Rank: 22
Omega Ratio Rank
JSPR Calmar Ratio Rank: 33
Calmar Ratio Rank
JSPR Martin Ratio Rank: 1414
Martin Ratio Rank

GD
GD Risk / Return Rank: 7575
Overall Rank
GD Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
GD Sortino Ratio Rank: 7474
Sortino Ratio Rank
GD Omega Ratio Rank: 7272
Omega Ratio Rank
GD Calmar Ratio Rank: 7373
Calmar Ratio Rank
GD Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JSPR vs. GD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jasper Therapeutics, Inc. (JSPR) and General Dynamics Corporation (GD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


JSPRGDDifference
Sharpe ratioReturn per unit of total volatility

-2.02

Sortino ratioReturn per unit of downside risk

-3.77

Omega ratioGain probability vs. loss probability

0.73

1.23

-0.50

Calmar ratioReturn relative to maximum drawdown

-0.97

1.76

-2.73

Martin ratioReturn relative to average drawdown

-1.23

6.00

-7.23

JSPR vs. GD - Sharpe Ratio Comparison

The current JSPR Sharpe Ratio is -0.85, which is lower than the GD Sharpe Ratio of 1.16. The chart below compares the historical Sharpe Ratios of JSPR and GD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

JSPR vs. GD - Drawdown Comparison

The maximum JSPR drawdown since its inception was -99.72%, which is greater than GD's maximum drawdown of -75.67%. Use the drawdown chart below to compare losses from any high point for JSPR and GD.


Loading charts...

Drawdown Indicators


JSPRGDDifference

Max Drawdown

Largest peak-to-trough decline

-99.72%

-75.67%

-24.05%

Max Drawdown (1Y)

Largest decline over 1 year

-93.37%

-14.53%

-78.84%

Max Drawdown (3Y)

Largest decline over 3 years

-98.49%

-22.55%

-75.94%

Max Drawdown (5Y)

Largest decline over 5 years

-22.55%

Max Drawdown (10Y)

Largest decline over 10 years

-51.63%

Current Drawdown

Current decline from peak

-99.69%

-6.10%

-93.59%

Average Drawdown

Average peak-to-trough decline

-88.49%

-15.60%

-72.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

73.29%

4.25%

+69.04%

Volatility

JSPR vs. GD - Volatility Comparison

Jasper Therapeutics, Inc. (JSPR) has a higher volatility of 48.15% compared to General Dynamics Corporation (GD) at 8.30%. This indicates that JSPR's price experiences larger fluctuations and is considered to be riskier than GD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JSPRGDDifference

Volatility (1M)

Calculated over the trailing 1-month period

48.15%

8.30%

+39.85%

Volatility (6M)

Calculated over the trailing 6-month period

76.45%

18.20%

+58.25%

Volatility (1Y)

Calculated over the trailing 1-year period

106.07%

22.01%

+84.06%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

241.69%

20.57%

+221.12%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

241.69%

22.80%

+218.89%

Dividends

JSPR vs. GD - Dividend Comparison

JSPR has not paid dividends to shareholders, while GD's dividend yield for the trailing twelve months is around 1.77%.


PositionTTM20252024202320222021202020192018201720162015
GD
General Dynamics Corporation
1.77%1.76%2.12%2.01%2.00%2.24%2.90%2.26%2.31%1.61%1.72%1.96%
JSPR
Jasper Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

JSPR vs. GD - Financials Comparison

This section allows you to compare key financial metrics between Jasper Therapeutics, Inc. and General Dynamics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B202220232024202520260
13.48B
(JSPR) Total Revenue
(GD) Total Revenue
Values in USD except per share items

Frequently Asked Questions


JSPR and GD have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

JSPR has higher volatility (48.15%) compared to GD (8.30%). In terms of maximum drawdown, JSPR dropped -99.72% vs GD's -75.67%.

GD currently has the higher Sharpe Ratio (1.16 vs -0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JSPR and GD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer